Stockman Wealth Management Inc. Sells 1,765 Shares of Abrdn Healthcare Investors (NYSE:HQH)

Stockman Wealth Management Inc. trimmed its holdings in Abrdn Healthcare Investors (NYSE:HQH) by 7.4% in the third quarter, Holdings Channel reports. The fund owned 21,944 shares of the financial services provider’s stock after selling 1,765 shares during the period. Stockman Wealth Management Inc.’s holdings in Abrdn Healthcare Investors were worth $409,000 at the end of the most recent quarter.

Other large investors also recently made changes to their positions in the company. Northwest Investment Counselors LLC bought a new position in Abrdn Healthcare Investors in the 3rd quarter valued at about $57,000. EverSource Wealth Advisors LLC bought a new stake in shares of Abrdn Healthcare Investors during the second quarter worth $93,000. Rothschild Investment LLC acquired a new position in Abrdn Healthcare Investors in the 2nd quarter worth about $101,000. Teamwork Financial Advisors LLC bought a new position in Abrdn Healthcare Investors in the 3rd quarter valued at approximately $201,000. Finally, Truist Financial Corp increased its holdings in Abrdn Healthcare Investors by 11.9% in the second quarter. Truist Financial Corp now owns 12,730 shares of the financial services provider’s stock valued at $222,000 after purchasing an additional 1,355 shares during the period. Institutional investors own 32.60% of the company’s stock.

Abrdn Healthcare Investors Price Performance

HQH stock traded up $0.25 during midday trading on Friday, hitting $18.68. The stock had a trading volume of 108,665 shares, compared to its average volume of 113,820. The business has a fifty day moving average price of $18.54 and a two-hundred day moving average price of $17.99. Abrdn Healthcare Investors has a 1-year low of $14.58 and a 1-year high of $19.79.

Abrdn Healthcare Investors Company Profile

Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries.